Mural Oncology plc Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Mural Oncology plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q3 2024.
Mural Oncology plc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.03M, a 65.5% decline year-over-year.
Mural Oncology plc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $19.7M.
Mural Oncology plc annual Share-based Payment Arrangement, Expense for 2023 was $24.1M, a 102% increase from 2022.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$19.7M	$1.03M	-$1.95M	-65.5%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$21.6M	$1.19M	-$1.95M	-62.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$23.6M	$2.2M	-$554K	-20.1%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$24.1M	$15.2M			Oct 1, 2023	Dec 31, 2023	10-K	2024-03-26
Q3 2023		$2.98M	-$496K	-14.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-13
Q2 2023		$3.14M			Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023		$2.75M			Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-14
Q3 2022		$3.48M			Jul 1, 2022	Sep 30, 2022	10-Q	2023-12-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.